Senior insider sale
Chief Medical Officer at NUVATION BIO INC. — senior position signals high conviction
$1.62M
220K shares
What this filing means
LIU DONGFANG plans to sell 220K shares of NUVATION BIO INC. valued at approximately $1.62M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/1/2025ACC: 0001950047-25-009581
Officer· Chief Medical Officer
Since Jul 2022
220K
Shares to sell
$1.62M
Approx. market value
150K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
12/1/2025
150KTotal acquired150K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/1/2025 | Exercise of options under a registered plan Cash | 150K | — |
| Total | 150K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
10K
Market value
$80.0K
11/26/2025
—Completed
Units to sell
10K
Market value
$75.0K
11/25/2025
—Completed
Units to sell
20K
Market value
$140.1K
11/20/2025
—Completed
Units to sell
15K
Market value
$76.6K
11/19/2025
—Completed
Units to sell
15K
Market value
$71.5K
11/17/2025
Planned — Approximate Date
NYSEPlanned
Units to sell
150K
Market value
$1.17M
12/1/2025
Total
Units
220K
Value
$1.62M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/26/2025 | 10K | $80.0K | — | Completed |
11/25/2025 | 10K | $75.0K | — | Completed |
11/20/2025 | 20K | $140.1K | — | Completed |
11/19/2025 | 15K | $76.6K | — | Completed |
11/17/2025 | 15K | $71.5K | — | Completed |
| Planned — Approximate Date | ||||
12/1/2025 | 150K | $1.17M | NYSE | Planned |
| Total | 220K | $1.62M | ||